| RS1553259649 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259651 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259656 |
MPZ
|
Health Risk |
Likely pathogenic |
Dejerine-Sottas disease, Dejerine-Sottas disease |
| RS1553259662 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259663 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259664 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1553259683 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259691 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259697 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259703 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259707 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease |
| RS1553259760 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259790 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259792 |
MPZ
|
Health Risk |
Likely pathogenic |
— |
| RS1553259811 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1553259835 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1553260014 |
MPZ
|
Health Risk |
Pathogenic |
— |
| RS1553260017 |
MPZ
|
Health Risk |
Pathogenic |
— |
| RS1553260321 |
CRB1
|
Health Risk |
Pathogenic |
Macular dystrophy, Retinitis pigmentosa 12 |
| RS1553260517 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553260596 |
SDHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1553261118 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553261372 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553261387 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553261461 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553261464 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553261468 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1553261476 |
USH2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553261478 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553261479 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553261757 |
SDHC
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553261768 |
SDHC
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Gastrointestinal stromal tumor |
| RS1553261855 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Primary dilated cardiomyopathy |
| RS1553261858 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to LMNA mutation, Charcot-Marie-Tooth disease type 2 |
| RS1553261891 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Congenital muscular dystrophy due to LMNA mutation |
| RS1553261898 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553261977 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553261982 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553262007 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Emery-Dreifuss muscular dystrophy 2 |
| RS1553262031 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553262199 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS1553262411 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553262429 |
GJC2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553262430 |
GJC2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553262438 |
GJC2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1553262444 |
SDHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1553262546 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553262957 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553263218 |
CRB1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 12 |
| RS1553263326 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hereditary insensitivity to pain with anhidrosis |
| RS1553263549 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553263572 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1553263639 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553263680 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Hereditary spastic paraplegia 74 |
| RS1553263732 |
RYR2
|
Health Risk |
Likely pathogenic |
— |
| RS1553263875 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1553263907 |
RYR2
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553264033 |
KIF14
|
Health Risk |
Pathogenic |
Microcephaly 20, primary |
| RS1553264036 |
KIF14
|
Health Risk |
Pathogenic |
Microcephaly 20, primary |
| RS1553264218 |
SDHC
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1553264593 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553264624 |
LMNA
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, Muscular dystrophy |
| RS1553264644 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553264647 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, 11 conditions |
| RS1553264668 |
LMNA
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS1553264669 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS1553264725 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS1553264773 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS1553264873 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS1553265154 |
ASH1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS1553265165 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553265177 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1553265180 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS1553265189 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS1553265328 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553265342 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553265369 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, Charcot-Marie-Tooth disease type 2 |
| RS1553265433 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, Charcot-Marie-Tooth disease type 2 |
| RS1553265436 |
LMNA
|
Health Risk |
Pathogenic |
Muscular dystrophy, Muscular dystrophy |
| RS1553265455 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1553265606 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1553265630 |
LMNA
|
Health Risk |
Pathogenic |
— |
| RS1553265647 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiomyopathy |
| RS1553265660 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1553265733 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553265736 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1A, Charcot-Marie-Tooth disease type 2 |
| RS1553265739 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS1553265755 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1553265760 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553265761 |
LMNA
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, Emery-Dreifuss muscular dystrophy 2 |
| RS1553265770 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553265794 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553265817 |
SDHC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1553265829 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553265865 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1553265902 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553265924 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553265999 |
LMNA
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant |
| RS1553266024 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553266048 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |